FDA Inspection 1116449 — Garonit Pharmaceutical, Inc.
The FDA completed an inspection of Garonit Pharmaceutical, Inc. on Jan 14, 2020 in Fairfield, NJ. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Veterinary.
Inspection details
- Classification
- Voluntary Action Indicated (VAI)
- End Date
- Jan 14, 2020
- Fiscal Year
- 2020
- Product Type
- Veterinary
- Project Area
- Monitoring of Marketed Animal Drugs, Feed, and Devices
- Location
- Fairfield, NJ (United States)